BeBetter, Trinomab Advance IPOs On China’s STAR Market In Firsts Since Policy Easing

 
• By Dexter Jie Yan
  
Going public
BeBetter Med and Zhuhai Trinomab Pharmaceutical are a step closer to IPOs on the STAR Market of Shanghai Stock Exchange. • Source: Shutterstock

More from Financing

More from Business